CATS:OTC-Catasys, Inc (USD)

COMMON STOCK | Medical Care Facilities | OTC

Last Closing Price

USD 74.56

Change

0.00 (0.00)%

Market Cap

USD 0.44B

Volume

0.79M

Average Target Price

USD 35.00 (-53.06%)
Average Analyst Rating

Verdict

Fundamental Analysis

Verdict

About

Ontrak, Inc. operates as an artificial intelligence powered, virtualized outpatient healthcare treatment company that provides in-person or telehealth intervention services to health plans and other third-party payors. Its Ontrak PRE (Predict-Recommend-Engage) platform predicts people whose chronic disease will improve with behavior change, recommends care pathways that people are willing to follow, and engages people who aren't getting the care they need. The company's technology-enabled, OnTrak, program is designed to treat health plan members with unaddressed behavioral health conditions that cause or exacerbate chronic medical diseases, such as diabetes, hypertension, coronary artery disease, COPD, and congestive heart failure. The OnTrak integrates evidence-based psychosocial and medical interventions delivered in-person or via telehealth along with care coaching and in-market community care coordinators who address the social and environmental determinants of health. The company was formerly known as Catasys, Inc. and changed its name to Ontrak, Inc. in July 2020. The company was founded in 2003 and is headquartered in Santa Monica, California.

Technical Indicators

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2020-09-21 )

Largest Industry Peers for Medical Care Facilities

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
FSNUF Fresenius SE & Co. KGaA

N/A

USD30.88B 11.71 8.03
FSNUY Fresenius SE & Co. KGaA

-0.41 (-3.51%)

USD30.41B 12.20 8.10
FMCQF Fresenius Medical Care AG & Co..

N/A

USD26.53B 16.79 9.73
IHHHF IHH Healthcare Berhad

N/A

USD11.34B 950.40 6.76
RMYHY Ramsay Health Care Limited

N/A

USD11.24B 46.97 11.81
RMSYF Ramsay Health Care Limited

N/A

USD11.24B 48.07 11.81
SKHHY Sonic Healthcare Limited

+0.33 (+1.41%)

USD11.14B 28.52 16.73
SKHCF Sonic Healthcare Limited

+0.80 (+3.42%)

USD11.03B 29.24 16.73
BDUUF Bangkok Dusit Medical Services..

N/A

USD10.53B 28.12 0.64
BDULF Bangkok Dusit Medical Services..

N/A

USD10.53B 38.65 0.64

ETFs Containing CATS

Symbol Name Weight Mer Price(Change) Market Cap

N/A

Market Performance

  Market Performance vs.
Industry/Classification (Medical Care Facilities)
Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 357.14% 96% A 94% A
Dividend Return N/A N/A N/A N/A N/A
Total Return 357.14% 96% A 94% A
Trailing 12 Months  
Capital Gain 321.48% 99% A+ 94% A
Dividend Return N/A N/A N/A N/A N/A
Total Return 321.48% 99% A+ 94% A
Trailing 5 Years  
Capital Gain 10,551.43% 100% A+ 98% A+
Dividend Return N/A N/A N/A N/A N/A
Total Return 10,551.43% 100% A+ 98% A+
Average Annual (5 Year Horizon)  
Capital Gain 173.42% N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return 173.42% N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 145.43% N/A N/A N/A N/A
Risk Adjusted Return 119.24% N/A N/A N/A N/A
Market Capitalization 0.44B 69% D+ 66% D
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 97%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Key Financial Ratios

  Ratio vs. Industry/Classification
(Medical Care Facilities)
Ratio vs. Market
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 23.90 46% F 31% F
Price/Book Ratio N/A N/A N/A N/A N/A
Price / Cash Flow Ratio -26.13 93% A 91% A-
EV/EBITDA N/A N/A N/A N/A N/A
Management Effectiveness  
Return on Equity N/A N/A N/A N/A N/A
Return on Invested Capital -646.13% 4% F 2% F
Return on Assets -91.36% 5% F 13% F
Debt to Equity Ratio -132.16% 93% A 96% A
Technical Ratios  
Short Ratio 9.47 67% D+ 10% F
Short Percent 45.19% 50% F 10% F
Beta 2.22 19% F 17% F
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 97%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

Fundamental Analysis Breakdown

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior Revenue Growth

This stock has shown top quartile revenue growth in the previous 5 years compared to its sector.

High Gross Profit to Asset Ratio

This stock is in the top quartile compared to its peers on Gross Profit to Asset Ratio. This is a popular measure among value investors for showing superior returns in the long run.

What to not like:
Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Negative cashflow

The company had negative total cash flow in the most recent four quarters.